Swiss stocks - Factors to watch on March 6

Novartis AG

06/03/2026 05:57

ZURICH/GDANSK, March 6 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday:

ROCHE ROG.S

Roche said on Thursday its experimental obesity drug, which is in development in collaboration with Denmark's Zealand Pharma ZELA.CO, helped patients lose up to 10.7% of their body weight in a mid-stage study.

UBS GROUP UBSG.S

The FT reports that UBS fee-sharing deals with Carlyle and CVC spark conflict of interest fears.

COMPANY STATEMENTS

* Swiss Prime Site SPSN.S - announces the conversion price of CHF 350 million green convertible bonds due 2032

* SFS Group SFSN.S - says 2025 revenue rises on diverse market presence

* Comet Holding COTNE.S - announces FY net sales increase of 2.6% to CHF 457 million

* Mobilezone MOZN.S - says 2025 gross profit was CHF 118 million

ANNUAL GENERAL MEETINGS

NOVARTIS NOVN.S - 3.7 CHF/shr dividend proposed

ECONOMY

Swiss February Forex reserves due at 0800 GMT.

 (Reporting by Zurich newsroom and Gdansk newsroom)

 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS